Menu
Back to User profile » Ms Jie Huang
Papers published by Ms Jie Huang:
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects
Ma J, Huang J, Zou C, Wu Q, Xie J, Zhang X, Yang X, Yang S, Wu Z, Jiang Y, Yu S, Zhang X, Yang G, Li M
Drug Design, Development and Therapy 2023, 17:2303-2313
Published Date: 3 August 2023
Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets
Feng Z, Liu Y, Kuang Y, Yang S, Li J, Ye L, Huang J, Pei Q, Huang Y, Yang G
Drug Design, Development and Therapy 2022, 16:3-12
Published Date: 3 January 2022
Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
Wang MN, Yu HT, Li YQ, Zeng Y, Yang S, Yang GP, Pei Q, Huang J
Drug Design, Development and Therapy 2021, 15:185-193
Published Date: 14 January 2021
Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects
Ning X, Kuang Y, Zhao S, Hou W, Yang G, Zhu XR, Liu R, Huang J
Journal of Asthma and Allergy 2020, 13:471-481
Published Date: 13 October 2020
Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study
Wang J, Huang J, Yang S, Cui C, Ye L, Wang S, Yang G, Pei Q
Drug Design, Development and Therapy 2019, 13:4135-4144
Published Date: 6 December 2019
Pharmacokinetics of single- and multiple-dose roflumilast: an open-label, three-way crossover study in healthy Chinese volunteers
Huang J, Fu CX, Yang XY, Cui C, Yang S, Kuang Y, Guo CX, Hu P, Pei Q, Yang GP
Drug Design, Development and Therapy 2018, 12:4047-4057
Published Date: 26 November 2018